nasopharyngeal carcinoma
Conditions
Interventions
Group 1:Given a Kangfuxin liquid combined with ice-throat 30-minute engraved sugar 30-minute
Control group:Compound tea polyphenols containing sputum.
Sponsors
Guizhou Provincial Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 69 Years
Inclusion criteria
Inclusion criteria: (1) Voluntarily participate in the trial and sign an informed consent form; (2) Aged 18 to 69 years old male and female; (3) Patients with newly diagnosed nasopharyngeal carcinoma confirmed by histopathology and without distant metastasis; (4) 2017 AJCC 8th edition clinical stage of nasopharyngeal carcinoma is stage III-IVA. (5) It is scheduled to receive radical chemoradiotherapy (IMRT technology for radiotherapy and cisplatin for chemotherapy); (6) KPS = 70; (7) The estimated survival period is at least 6 months.
Exclusion criteria
Exclusion criteria: (1) active oral infectious diseases, including oropharyngeal candidiasis and facial herpes, or other oral diseases; (2) elderly patients with dry stomatitis; (3) patients with recurrent or residual nasopharyngeal carcinoma; (4) Combine severe heart, liver, kidney, hematopoietic and neurological diseases, psychiatric patients, and those who are not satisfied with glycemic control of diabetes; (5) Patients who are simultaneously using molecular targeted therapy; (6) Those who are allergic to the body, who are known or suspected to be allergic to the test drug; (7) pregnant women, lactating women, and women of childbearing age who cannot be effectively contraceptive during the trial; (8) Those who have participated in other drug clinical trials within 3 months; (9) Alcohol and/or drug abusers;There are other researchers who think that it is not suitable for this test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute oral mucosal toxicity evaluation;Oral mucositis rating scale ulcer score;Pain rating;KPS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| 6/5000 Shengmìng zhìliàng cèdìng Quality of life measurement; | — |
Countries
China
Contacts
Public ContactLi Yuanyuan
The Cancer Hospital of GuiZhou Province
Outcome results
None listed